scholarly article | Q13442814 |
P356 | DOI | 10.1177/1535370213498979 |
P698 | PubMed publication ID | 24006304 |
P2093 | author name string | Li Shen | |
Cheng-Hai Liu | |||
Yan-Yan Tao | |||
Wen-Wei Fu | |||
Qing-Lan Wang | |||
P2860 | cites work | Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor | Q28507865 |
Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis | Q28566912 | ||
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver | Q29616840 | ||
A solid-phase extraction method for high-performance liquid chromatographic determination of salvianolic acid B in rabbit plasma: application to pharmacokinetic study | Q33269113 | ||
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways | Q35163498 | ||
Hepatic fibrosis: molecular mechanisms and drug targets | Q35911848 | ||
Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. | Q36308206 | ||
Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling | Q36456025 | ||
Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. | Q36601226 | ||
Hepatic fibrosis -- overview | Q37228945 | ||
Effect of Fuzheng Huayu formula and its actions against liver fibrosis | Q37289563 | ||
Pathogenesis of liver fibrosis | Q37809079 | ||
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. | Q37880150 | ||
Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. | Q38358348 | ||
Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells | Q39685359 | ||
Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation | Q40728276 | ||
C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis. | Q40831781 | ||
Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations | Q42279177 | ||
Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. | Q42856019 | ||
Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. | Q45980038 | ||
In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells | Q46824760 | ||
P433 | issue | 11 | |
P304 | page(s) | 1284-1296 | |
P577 | publication date | 2013-09-04 | |
P1433 | published in | Experimental Biology and Medicine | Q15716535 |
P1476 | title | Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. | |
P478 | volume | 238 |
Q38588143 | A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives |
Q36729351 | MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. |
Q38223369 | Pathogenesis of liver cirrhosis |
Q38326327 | Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis |
Q50055024 | Salvianolate reduces glucose metabolism disorders in dimethylnitrosamine-induced cirrhotic rats |
Q37039390 | Salvianolic Acid B Prevents Iodinated Contrast Media-Induced Acute Renal Injury in Rats via the PI3K/Akt/Nrf2 Pathway |
Q53634280 | Salvianolic Acid B Protects Normal Human Dermal Fibroblasts Against Ultraviolet B Irradiation-Induced Photoaging Through Mitogen-Activated Protein Kinase and Activator Protein-1 Pathways. |
Q64229967 | Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer |
Q41520562 | Salvianolic acid B regulates gene expression and promotes cell viability in chondrocytes |
Q36232847 | Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. |
Q47334982 | Simvastatin augments activation of liver regeneration through attenuating transforming growth factor-β1 induced-apoptosis in obstructive jaundice rats |
Q38257833 | Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities |
Search more.